| [1] |
Zanoni DK, Montero PH, Migliacci JC, et al. Survival outcomes after treatment of cancer of the oral cavity (1985—2015)[J]. Oral Oncol, 2019, 90: 115-121.
doi: 10.1016/j.oraloncology.2019.02.001
|
| [2] |
Carnielli CM, Macedo CCS, De Rossi T, et al. Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer[J]. Nat Commun, 2018, 9: 3598.
doi: 10.1038/s41467-018-05696-2
pmid: 30185791
|
| [3] |
Zhang Z, Pan J, Li LJ, et al. Survey of risk factors contributed to lymphatic metastasis in patients with oral tongue cancer by immunohistochemistry[J]. J Oral Pathol Med, 2011, 40(2): 127-134.
doi: 10.1111/j.1600-0714.2010.00953.x
pmid: 20969624
|
| [4] |
Domingueti CB, Castilho DAQ, de Oliveira CE, et al. Eukaryotic translation elongation factor 1δ, N-terminal propeptide of type Ⅰ collagen and cancer-associated fibroblasts are prognostic markers of oral squamous cell carcinoma patients[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2020, 130(6): 700-707.e2.
doi: 10.1016/j.oooo.2020.09.003
|
| [5] |
Wu YH, Chang TH, Huang YF, et al. COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer[J]. Oncogene, 2014, 33(26): 3432-3440.
doi: 10.1038/onc.2013.307
pmid: 23934190
|
| [6] |
Tuly KF, Hossen MB, Islam MA, et al. Robust identification of differential gene expression patterns from multiple transcriptomics datasets for early diagnosis, prognosis, and therapies for breast cancer[J]. Medicina (Kaunas), 2023, 59(10): 1705.
|
| [7] |
García-Pravia C, Galván JA, Gutiérrez-Corral N, et al. Overexpression of COL11A1 by cancer-associated fibroblasts: Clinical relevance of a stromal marker in pancreatic cancer[J]. PLoS One, 2013, 8(10): e78327.
doi: 10.1371/journal.pone.0078327
|
| [8] |
Fischer H, Stenling R, Rubio C, et al. Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2[J]. Carcinogenesis, 2001, 22(6): 875-878.
doi: 10.1093/carcin/22.6.875
pmid: 11375892
|
| [9] |
Jia DY, Liu ZQ, Deng N, et al. A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets[J]. Cancer Lett, 2016, 382(2): 203-214.
doi: S0304-3835(16)30513-4
pmid: 27609069
|
| [10] |
Tian CX, Clauser KR, Öhlund D, et al. Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells[J]. Proc Natl Acad Sci USA, 2019, 116(39): 19609-19618.
doi: 10.1073/pnas.1908626116
pmid: 31484774
|
| [11] |
Tharp KM, Kersten K, Maller O, et al. Tumor-associated macrophages restrict CD8+ T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenviron-ment[J]. Nat Cancer, 2024, 5(7): 1045-1062.
doi: 10.1038/s43018-024-00775-4
|
| [12] |
Ding L, Fu Y, Zhu NS, et al. OXTRHigh stroma fibroblasts control the invasion pattern of oral squamous cell carcinoma via ERK5 signaling[J]. Nat Commun, 2022, 13(1): 5124.
doi: 10.1038/s41467-022-32787-y
|
| [13] |
Zhang JY, Lu SQ, Lu T, et al. Single-cell analysis reveals the COL11A1+ fibroblasts are cancer-specific fibroblasts that promote tumor progression[J]. Front Pharmacol, 2023, 14: 1121586.
doi: 10.3389/fphar.2023.1121586
|
| [14] |
Lieu EL, Nguyen T, Rhyne S, et al. Amino acids in cancer[J]. Exp Mol Med, 2020, 52(1): 15-30.
doi: 10.1038/s12276-020-0375-3
pmid: 31980738
|
| [15] |
Liu XH, Ren B, Ren J, et al. The significant role of amino acid metabolic reprogramming in cancer[J]. Cell Commun Signal, 2024, 22(1): 380.
doi: 10.1186/s12964-024-01760-1
pmid: 39069612
|
| [16] |
Carlisle AE, Lee N, Matthew-Onabanjo AN, et al. Selenium detoxification is required for cancer-cell survival[J]. Nat Metab, 2020, 2(7): 603-611.
doi: 10.1038/s42255-020-0224-7
pmid: 32694795
|
| [17] |
Yuan ZN, Li YP, Zhang SF, et al. Extracellular matrix remodeling in tumor progression and immune escape: From mechanisms to treatments[J]. Mol Cancer, 2023, 22(1): 48.
doi: 10.1186/s12943-023-01744-8
pmid: 36906534
|
| [18] |
Luo Q, Li JS, Su XH, et al. COL11A1 serves as a biomarker for poor prognosis and correlates with immune infiltration in breast cancer[J]. Front Genet, 2022, 13: 935860.
doi: 10.3389/fgene.2022.935860
|
| [19] |
Yan YL, Sun DQ, Hu JJ, et al. Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer[J]. Nat Genet, 2025, 57(1): 126-139.
doi: 10.1038/s41588-024-01998-y
pmid: 39658657
|
| [20] |
Zheng HS, Tan J, Qin F, et al. Analysis of cancer-associated fibroblasts related genes identifies COL11A1 associated with lung adenocarcinoma prognosis[J]. BMC Med Genomics, 2024, 17(1): 97.
doi: 10.1186/s12920-024-01863-1
pmid: 38649961
|